Ashkon Software







 

PLUR Stock - Pluri Inc.


PLUR Stock Chart

PLUR Profile

Pluri Inc. logo

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

PLUR Revenue Chart


 

Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer